Access to ccess to vaccination against COVID-19 is a public health priority and essential for each patient concerned. In order to protect immunocompromised persons, vaccination of their family and friends and the respect of barrier measures remain the best means to avoid contamination.
Treatments are now available to reduce the risk of developing COVID 19 in the event of contact with a carrier or of developing a severe form in the event of proven contamination.
The Vaccine Strategy Steering Committee published on March 28, 2022 an update of the recommendations for protection (vaccination and prophylaxis) against Covid-19 for profoundly immunocompromised persons.
We therefore advise you to contact the department of the hospital where you are being treated and your referring physician to find out what to do in your particular case, in case of contact with a person with COVID 19 or if you yourself are affected.
Previous recommendations can be found here:
The decree of 26/03/2022 expanding the indications and specifying the modalities of vaccination against COVID-19 for immunocompromised patients (by disease or treatment: long-term corticosteroids, immunosuppressants, Rituximab or other biotherapy), marrow and organ transplant patients and certain other conditions.
The recommendations of the SFGM-TC of 13/01/2022 completing the DGS circular of 04/01/2022
Summary of the COVID 19 MATHEC Prophylaxis Strategy of 22/04/2022
Our mission
To further knowledge, improve clinical practice, patient care, and tranlational research into the clinical and biological follow-up of patients with autoimmune diseases treated with bone marrow transplant and other stem cell therapies in France.
The proceedings of the MATHEC Friday of 20/05/2022 on Mesenchymal Stem Cell are available here

The next MATHEC Friday meeting will be held on 07/22/2022 on "Stem Cell therapy in Multiples Sclerosis" at 1pm.
To connect to the zoom meeting: click here
Meeting ID: 922 1702 4011 Password : qed7hw